In its recent review of a district court decision the Federal Circuit characterized as “a thorough opinion,” the Federal Circuit affirmed invalidation for obviousness of four claims from four different Orange Book-listed patents in Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc….
By: McDonnell Boehnen Hulbert & Berghoff LLP
By: McDonnell Boehnen Hulbert & Berghoff LLP
